Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Altamira Therapeutics FY EPS $(16.47) Sales $284.47K Down From $330.37K YoY

Author: Benzinga Newsdesk | April 10, 2024 09:21am
Altamira Therapeutics (NASDAQ:CYTO) reported quarterly losses of $(16.47) per share. This is a 97.38 percent increase over losses of $(629.80) per share from the same period last year. The company reported $284.47 thousand in sales this quarter. This is a 13.89 percent decrease over sales of $330.37 thousand the same period last year.

Posted In: CYTO


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist